Literature DB >> 16840535

Correlation between FOXO1a (FKHR) and FOXO3a (FKHRL1) binding and the inhibition of basal glucose-6-phosphatase catalytic subunit gene transcription by insulin.

Hiroshi Onuma1, Beth T Vander Kooi, Jared N Boustead, James K Oeser, Richard M O'Brien.   

Abstract

Insulin inhibits transcription of the genes encoding the glucose-6-phosphatase catalytic subunit (G6Pase), phosphoenolpyruvate carboxykinase, and IGF binding protein-1 through insulin response sequences (IRSs) that share the same core sequence, T(G/A)TTTT(G/T). The transcription factors FOXO1a and FOXO3a have been shown to bind these elements, but there are conflicting reports as to whether this binding correlates with the action of insulin on gene transcription. Some researchers concluded, from overexpression experiments using FOXO1a, that binding correlated with the insulin response, whereas others concluded, mainly from gel retardation competition experiments using FOXO3a, that it did not. We show here that, although these factors can differentially activate gene transcription in a context-dependent manner, these conflicting data are not explained by a difference in FOXO1a and FOXO3a binding specificity. Instead, we find that gel retardation competition and binding experiments give different results; the latter reveal a correlation between FOXO1a/3a binding and the inhibition of basal G6Pase gene transcription by insulin. In addition, these data show that the binding of FOXO1a/3a to two adjacent IRSs in the G6Pase promoter is cooperative and that promoter context alters the specific IRS base requirements for FOXO1a-stimulated fusion gene expression. Surprisingly, an analysis of insulin action mediated through the G6Pase and IGF binding protein-1 IRSs in the context of a heterologous thymidine kinase promoter reveals that signaling through the latter does not support the accepted model for insulin-stimulated FOXO nuclear exclusion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16840535     DOI: 10.1210/me.2006-0085

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  37 in total

1.  Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice.

Authors:  Kebin Zhang; Ling Li; Yajuan Qi; Xiaoping Zhu; Boyi Gan; Ronald A DePinho; Travis Averitt; Shaodong Guo
Journal:  Endocrinology       Date:  2011-12-06       Impact factor: 4.736

2.  Repression of glucocorticoid-stimulated angiopoietin-like 4 gene transcription by insulin.

Authors:  Taiyi Kuo; Tzu-Chieh Chen; Stephanie Yan; Fritz Foo; Cecilia Ching; Allison McQueen; Jen-Chywan Wang
Journal:  J Lipid Res       Date:  2014-02-24       Impact factor: 5.922

3.  In pursuit of genes of glucose metabolism.

Authors:  Daryl K Granner
Journal:  J Biol Chem       Date:  2015-07-24       Impact factor: 5.157

Review 4.  Deciphering the role of forkhead transcription factors in cancer therapy.

Authors:  Jer-Yen Yang; Mien-Chie Hung
Journal:  Curr Drug Targets       Date:  2011-08       Impact factor: 3.465

5.  Nuclear accumulation of β-catenin and forkhead box O3a in colon cancer: Dangerous liaison.

Authors:  Wolfgang Link
Journal:  World J Biol Chem       Date:  2012-09-26

6.  Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1.

Authors:  Hui Yan; Wangbao Yang; Fenghua Zhou; Xiaopeng Li; Quan Pan; Zheng Shen; Guichun Han; Annie Newell-Fugate; Yanan Tian; Ravikumar Majeti; Wenshe Liu; Yong Xu; Chaodong Wu; Kimberly Allred; Clinton Allred; Yuxiang Sun; Shaodong Guo
Journal:  Diabetes       Date:  2018-11-28       Impact factor: 9.461

7.  Sequence variation between the mouse and human glucose-6-phosphatase catalytic subunit gene promoters results in differential activation by peroxisome proliferator activated receptor gamma coactivator-1alpha.

Authors:  M M Schilling; J K Oeser; J K Chandy; B P Flemming; S R Allen; R M O'Brien
Journal:  Diabetologia       Date:  2008-06-19       Impact factor: 10.122

Review 8.  A new fork for clinical application: targeting forkhead transcription factors in cancer.

Authors:  Jer-Yen Yang; Mien-Chie Hung
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

Review 9.  Glucose-6-phosphatase catalytic subunit gene family.

Authors:  John C Hutton; Richard M O'Brien
Journal:  J Biol Chem       Date:  2009-08-20       Impact factor: 5.157

10.  Prolactin signaling through the short form of its receptor represses forkhead transcription factor FOXO3 and its target gene galt causing a severe ovarian defect.

Authors:  Julia Halperin; Y Sangeeta Devi; Sangeeta Y Devi; Shai Elizur; Carlos Stocco; Aurora Shehu; Diane Rebourcet; Terry G Unterman; Nancy D Leslie; Jamie Le; Nadine Binart; Geula Gibori
Journal:  Mol Endocrinol       Date:  2007-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.